For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $0.41 in the prior trading day, NeuBase Therapeutics Inc (NASDAQ: NBSE) closed at $0.41, down -1.72%. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 0.59 million shares were traded. NBSE stock price reached its highest trading level at $0.418 during the session, while it also had its lowest trading level at $0.4028.
Ratios:
Our goal is to gain a better understanding of NBSE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.87 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 12, 2021, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On June 16, 2020, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 14 ’23 when Symetryx Corp sold 129,108 shares for $1.44 per share. The transaction valued at 185,916 led to the insider holds 153,337 shares of the business.
Symetryx Corp sold 3,376 shares of NBSE for $4,861 on Sep 11 ’23. The 10% Owner now owns 472,926 shares after completing the transaction at $1.44 per share. On Sep 08 ’23, another insider, Symetryx Corp, who serves as the 10% Owner of the company, sold 128,847 shares for $1.53 each. As a result, the insider received 197,136 and left with 476,302 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBSE now has a Market Capitalization of 1519394 and an Enterprise Value of -5724865.
Stock Price History:
Over the past 52 weeks, NBSE has reached a high of $4.80, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -38.24%, while the 200-Day Moving Average is calculated to be -49.32%.
Shares Statistics:
The stock has traded on average 236.69K shares per day over the past 3-months and 84239 shares per day over the last 10 days, according to various share statistics. A total of 3.75M shares are outstanding, with a floating share count of 3.05M. Insiders hold about 18.62% of the company’s shares, while institutions hold 12.68% stake in the company. Shares short for NBSE as of 1713139200 were 24457 with a Short Ratio of 0.10, compared to 1710460800 on 80453. Therefore, it implies a Short% of Shares Outstanding of 24457 and a Short% of Float of 0.69999998.
